The Loncar China BioPharma Index tracks the performance of a basket of companies that are leading China’s biotech revolution. With a focus on innovators, the index contains globally listed pharmaceutical companies, biotech companies, drug manufacturers, diagnostics companies, wholesalers, distributors and service providers that have a strategic role in growing China’s drug industry. It uses a modified equal-weighting methodology and contains both large pharmaceutical and growth-oriented biotechnology companies that are leading the region’s growth. The index will provide a metric to follow as this region plays an increasingly important role in the global biopharmaceuticals industry.